GeneCure
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $230M
Overview
A gene therapy developer aiming to cure severe rare genetic diseases with single-administration treatments.
Rare DiseaseGenetics & Genomics
Technology Platform
A gene therapy platform utilizing engineered AAV vectors and gene editing tools for targeted delivery of therapeutic genes to treat monogenic disorders.
Funding History
1Total raised:$230M
PIPE$230M
Opportunities
Potential for transformative, curative therapies that command high value in underserved rare disease markets.
Risk Factors
Clinical safety risks (e.g., immune responses to vectors), high per-patient costs, and challenges in trial recruitment.
Competitive Landscape
Operates in a competitive rare disease gene therapy sector, differentiated by its specific disease selection and vector engineering.